1. Home
  2. PHK vs KURA Comparison

PHK vs KURA Comparison

Compare PHK & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHK
  • KURA
  • Stock Information
  • Founded
  • PHK 2003
  • KURA 2014
  • Country
  • PHK United States
  • KURA United States
  • Employees
  • PHK N/A
  • KURA N/A
  • Industry
  • PHK Finance/Investors Services
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PHK Finance
  • KURA Health Care
  • Exchange
  • PHK Nasdaq
  • KURA Nasdaq
  • Market Cap
  • PHK 842.0M
  • KURA 713.5M
  • IPO Year
  • PHK N/A
  • KURA N/A
  • Fundamental
  • Price
  • PHK $4.93
  • KURA $8.09
  • Analyst Decision
  • PHK
  • KURA Buy
  • Analyst Count
  • PHK 0
  • KURA 14
  • Target Price
  • PHK N/A
  • KURA $24.45
  • AVG Volume (30 Days)
  • PHK 491.5K
  • KURA 1.7M
  • Earning Date
  • PHK 01-01-0001
  • KURA 11-06-2025
  • Dividend Yield
  • PHK 12.61%
  • KURA N/A
  • EPS Growth
  • PHK N/A
  • KURA N/A
  • EPS
  • PHK N/A
  • KURA N/A
  • Revenue
  • PHK N/A
  • KURA $83,279,000.00
  • Revenue This Year
  • PHK N/A
  • KURA $60.25
  • Revenue Next Year
  • PHK N/A
  • KURA $155.10
  • P/E Ratio
  • PHK N/A
  • KURA N/A
  • Revenue Growth
  • PHK N/A
  • KURA N/A
  • 52 Week Low
  • PHK $4.13
  • KURA $5.41
  • 52 Week High
  • PHK $5.15
  • KURA $21.40
  • Technical
  • Relative Strength Index (RSI)
  • PHK 48.93
  • KURA 55.99
  • Support Level
  • PHK $4.93
  • KURA $8.09
  • Resistance Level
  • PHK $4.94
  • KURA $8.90
  • Average True Range (ATR)
  • PHK 0.04
  • KURA 0.51
  • MACD
  • PHK -0.01
  • KURA -0.05
  • Stochastic Oscillator
  • PHK 17.86
  • KURA 35.20

About PHK Pimco High Income Fund

PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Share on Social Networks: